Skip to main content
Journal of Medical BiochemistryVolume 43, Issue 3, 2024, Pages 424-435

PEDIATRIC NEPHROTIC SYNDROME: THE INTERPLAY OF OXIDATIVE STRESS AND INFLAMMATION(Article)(Open Access)

[PEDIJATRIJSKI NEFROTSKI SINDROM: ME\USOBNA INTERAKCIJA OKSIDATIVNOG STRESA I INFLAMACIJE]

  • Simachew, Y.M.,
  • Mihajlović, M.,
  • Antonić, T.,
  • Miloševski-Lomić, G.,
  • Peco-Antić, A.,
  • Jovanović, D.,
  • Paripovi, D.,
  • Stefanović, A.
  • View Correspondence (jump link)
  Save all to author list
  • aDepartment of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Serbia
  • bDepartment of Nephrology, University Children's Hospital, Belgrade, Serbia
  • cSchool of Medicine, University of Belgrade, Belgrade, Serbia
  • dInternal Medicine Clinic»Akta Medica«, Serbia

Abstract

Background: The pathophysiological mechanisms crucial in the development of nephrotic syndrome (NS) in the pediatric population are still not fully understood. This study aimed to investigate the relationship between hypertension, oxidative stress, and inflammation in pediatric patients during the acute phase of the disease. Methods: The study included 33 children, aged 2 to 9 years, with nephrotic syndrome. Blood samples were collected during the acute phase and remission. Parameters of oxidative status were determined, including total oxidative status (TOS), advanced oxidation protein products (AOPP), prooxidant-antioxidant balance (PAB), sulfhydryl groups (- SH), paraoxonase 1 (PON1), and total antioxidant status (TAS) in serum, measured spectrophotometrically. Inflammatory parameters such as pentraxin 3 (PTX3), leptin, programmed cell death ligand 1 (PD-L1), and E-cadherin were determined using enzyme-linked immunosorbent assay (ELISA). Results: Patients with nephrotic syndrome and hypertension had significantly higher levels of advanced oxidation protein products and total antioxidant status (p=0.029 and p=0.003, respectively). During the acute phase of the disease, lower activity of sulfhydryl groups and paraoxonase 1 was observed compared to remission (p<0.001, for both). Pentraxin 3 levels were higher, while leptin levels were lower during the acute phase (p<0.001, for both). Pentraxin 3 correlated with advanced oxidation protein products and total antioxidant status during the acute phase but not in remission (rs=0.42, p=0.027 and rs=0.43, p=0.025, respectively). A negative correlation between Advanced oxidation protein products and leptin was observed during the acute phase, which disappeared in remission (rs=-0.42, p=0.028). Conclusions: Results of this study show that hypertension influences oxidative stress markers, and decreased antioxidant capacity may contribute to nephrotic syndrome development. Pentraxin 3 appears as a potential disease activity marker, indicating a dynamic connection between inflammation and oxidative stress. Leptin may also play a role in oxidative stress in nephrotic syndrome. © 2024 Society of Medical Biochemists of Serbia. All rights reserved.

Author keywords

advanced oxidation protein productshypertensioninflammationnephrotic syndromeoxidative stresspentraxin 3

Indexed keywords

EMTREE drug terms:advanced oxidation protein productaryldialkylphosphatase 1leptinpentraxin 3prednisoloneprogrammed death 1 ligand 1thiol groupuvomorulin
EMTREE medical terms:Articleblood analysischildclinical articlecontrolled studydisease associationenzyme linked immunosorbent assayfemalehumanhypertensioninflammationlow drug dosemalenephrotic syndromeoxidative stresspediatric patientpreschool childremissionschool childspectrophotometrytotal antioxidant capacity

Chemicals and CAS Registry Numbers:

prednisolone, 50-24-8; uvomorulin, 112956-45-3

Device tradename:

  • Human Pentraxin3 DuoSet, R and D Systems, United States,
  • ILab 300+, Instrumentation Laboratory, Italy

Manufacturers:

Device manufacturer:

Instrumentation Laboratory;

Instrumentation Laboratory, Italy;

R and D Systems;

R and D Systems, United States

Funding details

Funding sponsor Funding number Acronym
University of Belgrade451-03-47/2023-01/200161UB
University of BelgradeUB
  • 1

    This work was supported by the Ministry of Science, Technological Development and Innovation, Republic of Serbia (Grant Agreement with the University of Belgrade, Faculty of Pharmacy No: 451-03-47/2023-01/200161)

  • 2

    Acknowledgments: This work was supported by the Ministry of Science, Technological Development

  • ISSN: 14528258
  • Source Type: Journal
  • Original language: English
  • DOI: 10.5937/jomb0-46526
  • Document Type: Article
  • Publisher: Society of Medical Biochemists of Serbia

  Simachew, Y.M.; Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Serbia;
© Copyright 2024 Elsevier B.V., All rights reserved.

Cited by 0 documents

{"topic":{"name":"Antioxidant; Superoxide Dismutase; Reactive Oxygen Species","id":75698,"uri":"Topic/75698","prominencePercentile":1.0358236,"prominencePercentileString":"1.036","overallScholarlyOutput":0},"dig":"f23a97b501b41d752c141f04e80e015988d141ad2c6dce0a57b9aedeb1ee44a9"}

SciVal Topic Prominence

Topic:
Prominence percentile: